skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


Title: Data-Driven Model Development for Cardiomyocyte Production Experimental Failure Prediction
Cardiovascular diseases (CVD) are the leading cause of death worldwide. Engineered heart tissue produced by differentiation of human induced pluripotent stem cells may provide an encompassing treatment for heart failure due to CVD. However, considerable difficulties exist in producing the large number of cardiomyocytes needed for therapeutic purposes through differentiation protocols. Data-driven modeling with machine learning techniques has the potential to identify factors that significantly affect the outcomes of these differentiation experiments. Using data from previous cardiac differentiation experiments, we have developed data-driven modeling methods for determining which experimental conditions are most influential on the final cardiomyocyte content of a differentiation experiment. With those identified conditions, we were able to build classification models that can predict whether an experiment will have a sufficient cardiomyocyte content to continue with the experiment on the seventh (out of 10) day of the differentiation with a 90% accuracy. This early failure prediction will provide cost and time savings, as each day the differentiation continues requires significant resources.  more » « less
Award ID(s):
1743445
PAR ID:
10187856
Author(s) / Creator(s):
; ; ; ; ; ;
Date Published:
Journal Name:
Computeraided Chemical Engineering
Volume:
48
ISSN:
1570-7946
Page Range / eLocation ID:
1640 - 1644
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. ; ; ; ; ; (, Journal of Advanced Manufacturing and Processing)
    Abstract This study employed machine learning (ML) models to predict the cardiomyocyte (CM) content following differentiation of human induced pluripotent stem cells (hiPSCs) encapsulated in hydrogel microspheroids and to identify the main experimental variables affecting the CM yield. Understanding how to enhance CM generation using hiPSCs is critical in moving toward large‐scale production and implementing their use in developing therapeutic drugs and regenerative treatments. Cardiomyocyte production has entered a new era with improvements in the differentiation process. However, existing processes are not sufficiently robust for reliable CM manufacturing. Using ML techniques to correlate the initial, experimentally specified stem cell microenvironment's impact on cardiac differentiation could identify important process features. The initial tunable (controlled) input features for training ML models were extracted from 85 individual experiments. Subsets of the controlled input features were selected using feature selection and used for model construction. Random forests, Gaussian process, and support vector machines were employed as the ML models. The models were built to predict two classes of sufficient and insufficient for CM content on differentiation day 10. The best model predicted the sufficient class with an accuracy of 75% and a precision of 71%. The identified key features including post‐freeze passage number, media type, PF fibrinogen concentration, CHIR/S/V, axial ratio, and cell concentration provided insight into the significant experimental conditions. This study showed that we can extract information from the experiments and build predictive models that could enhance the cell production process by using ML techniques. 
    more » « less
  2. ; (, IEEE)
    In the United States, heart disease is the leading cause of death, killing about 695,000 people each year. Myocardial infarction (MI) is a cardiac complication which occurs when blood flow to a portion of the heart decreases or halts, leading to damage in the heart muscle. Heart failure and Atrial fibrillation (AF) are closely associated with MI. Heart failure is a common complication of MI and a risk factor for AF. Machine learning (ML) and deep learning techniques have shown potential in predicting cardiovascular conditions. However, developing a sim- plified predictive model, along with a thorough feature analysis, is challenging due to various factors, including lifestyle, age, family history, medical conditions, and clinical variables for cardiac complications prediction. This paper aims to develop simplified models with comprehensive feature analysis and data preprocessing for predicting cardiac complications, such as heart failure and atrial fibrillation linked with MI, using a publicly available dataset of myocardial infarction patients. This will help the students and health care professionals understand various factors responsible for cardiac complications through a simplified workflow. By prioritizing interpretability, this paper illustrates how simpler models, like decision trees and logistic regression, can provide transparent decision-making processes while still maintaining a balance with accuracy. Additionally, this paper examines how age-specific factors affect heart failure and atrial fibrillation conditions. Overall this research focuses on making machine learning accessible and interpretable. Its goal is to equip students and non-experts with practical tools to understand how ML can be applied in healthcare, particularly for the cardiac complications prediction for patients having MI. 
    more » « less
  3. ; ; (, Frontiers in Cardiovascular Medicine)
    Cardiovascular disease is the leading cause of death worldwide and bears an immense economic burden. Late-stage heart failure often requires total heart transplantation; however, due to donor shortages and lifelong immunosuppression, alternative cardiac regenerative therapies are in high demand. Human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells, have emerged as a viable source of human cardiomyocytes for transplantation. Recent developments in several mammalian models of cardiac injury have provided strong evidence of the therapeutic potential of hPSC-derived cardiomyocytes (hPSC-CM), showing their ability to electromechanically integrate with host cardiac tissue and promote functional recovery. In this review, we will discuss recent developments in hPSC-CM differentiation and transplantation strategies for delivery to the heart. We will highlight the mechanisms through which hPSC-CMs contribute to heart repair, review major challenges in successful transplantation of hPSC-CMs, and present solutions that are being explored to address these limitations. We end with a discussion of the clinical use of hPSC-CMs, including hurdles to clinical translation, current clinical trials, and future perspectives on hPSC-CM transplantation. 
    more » « less
  4. ; ; ; ; (, Scientific Reports)
    Abstract Heart failure is a chronic disease, the symptoms of which occur due to a lack of cardiac output. It can be better managed with continuous and real time monitoring. Some efforts have been made in the past for the management of heart failure. Most of these efforts were based on a single parameter for example thoracic impedance or heart rate alone. Herein, we report a wearable device that can provide monitoring of multiple physiological parameters related to heart failure. It is based on the sensing of multiple parameters simultaneously including thoracic impedance, heart rate, electrocardiogram and motion activity. These parameters are measured using different sensors which are embedded in a wearable belt for their continuous and real time monitoring. The healthcare wearable device has been tested in different conditions including sitting, standing, laying, and walking. Results demonstrate that the reported wearable device keeps track of the aforementioned parameters in all conditions. 
    more » « less
  5. ; ; ; ; ; ; ; (, Cells)
    LMNA-related dilated cardiomyopathy (DCM) is an autosomal-dominant genetic condition with cardiomyocyte and conduction system dysfunction often resulting in heart failure or sudden death. The condition is caused by mutation in the Lamin A/C (LMNA) gene encoding Type-A nuclear lamin proteins involved in nuclear integrity, epigenetic regulation of gene expression, and differentiation. The molecular mechanisms of the disease are not completely understood, and there are no definitive treatments to reverse progression or prevent mortality. We investigated possible mechanisms of LMNA-related DCM using induced pluripotent stem cells derived from a family with a heterozygous LMNA c.357-2A>G splice-site mutation. We differentiated one LMNA-mutant iPSC line derived from an affected female (Patient) and two non-mutant iPSC lines derived from her unaffected sister (Control) and conducted single-cell RNA sequencing for 12 samples (four from Patients and eight from Controls) across seven time points: Day 0, 2, 4, 9, 16, 19, and 30. Our bioinformatics workflow identified 125,554 cells in raw data and 110,521 (88%) high-quality cells in sequentially processed data. Unsupervised clustering, cell annotation, and trajectory inference found complex heterogeneity: ten main cell types; many possible subtypes; and lineage bifurcation for cardiac progenitors to cardiomyocytes (CMs) and epicardium-derived cells (EPDCs). Data integration and comparative analyses of Patient and Control cells found cell type and lineage-specific differentially expressed genes (DEGs) with enrichment, supporting pathway dysregulation. Top DEGs and enriched pathways included 10 ZNF genes and RNA polymerase II transcription in pluripotent cells (PP); BMP4 and TGF Beta/BMP signaling, sarcomere gene subsets and cardiogenesis, CDH2 and EMT in CMs; LMNA and epigenetic regulation, as well as DDIT4 and mTORC1 signaling in EPDCs. Top DEGs also included XIST and other X-linked genes, six imprinted genes (SNRPN, PWAR6, NDN, PEG10, MEG3, MEG8), and enriched gene sets related to metabolism, proliferation, and homeostasis. We confirmed Lamin A/C haploinsufficiency by allelic expression and Western blot. Our complex Patient-derived iPSC model for Lamin A/C haploinsufficiency in PP, CM, and EPDC provided support for dysregulation of genes and pathways, many previously associated with Lamin A/C defects, such as epigenetic gene expression, signaling, and differentiation. Our findings support disruption of epigenomic developmental programs, as proposed in other LMNA disease models. We recognized other factors influencing epigenetics and differentiation; thus, our approach needs improvement to further investigate this mechanism in an iPSC-derived model. 
    more » « less
  • Citation Formats
  • MLA
  • APA
  • Chicago
  • BibTeX
  • Save / Share this Record
  • Send to Email